1. Home
  2. NDRA vs NXTT Comparison

NDRA vs NXTT Comparison

Compare NDRA & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDRA
  • NXTT
  • Stock Information
  • Founded
  • NDRA 2007
  • NXTT 2019
  • Country
  • NDRA United States
  • NXTT China
  • Employees
  • NDRA N/A
  • NXTT N/A
  • Industry
  • NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NXTT
  • Sector
  • NDRA Health Care
  • NXTT
  • Exchange
  • NDRA Nasdaq
  • NXTT NYSE
  • Market Cap
  • NDRA 2.3M
  • NXTT 1.9M
  • IPO Year
  • NDRA 2017
  • NXTT N/A
  • Fundamental
  • Price
  • NDRA $3.36
  • NXTT $1.36
  • Analyst Decision
  • NDRA Strong Buy
  • NXTT
  • Analyst Count
  • NDRA 1
  • NXTT 0
  • Target Price
  • NDRA $46.00
  • NXTT N/A
  • AVG Volume (30 Days)
  • NDRA 97.6K
  • NXTT 16.9M
  • Earning Date
  • NDRA 05-15-2025
  • NXTT 05-09-2025
  • Dividend Yield
  • NDRA N/A
  • NXTT N/A
  • EPS Growth
  • NDRA N/A
  • NXTT 21.23
  • EPS
  • NDRA N/A
  • NXTT 6.62
  • Revenue
  • NDRA N/A
  • NXTT $1,800,000.00
  • Revenue This Year
  • NDRA N/A
  • NXTT N/A
  • Revenue Next Year
  • NDRA N/A
  • NXTT N/A
  • P/E Ratio
  • NDRA N/A
  • NXTT $0.21
  • Revenue Growth
  • NDRA N/A
  • NXTT N/A
  • 52 Week Low
  • NDRA $2.90
  • NXTT $0.22
  • 52 Week High
  • NDRA $286.48
  • NXTT $6.00
  • Technical
  • Relative Strength Index (RSI)
  • NDRA 44.40
  • NXTT 45.21
  • Support Level
  • NDRA $3.31
  • NXTT $1.50
  • Resistance Level
  • NDRA $3.80
  • NXTT $2.89
  • Average True Range (ATR)
  • NDRA 0.26
  • NXTT 0.33
  • MACD
  • NDRA 0.04
  • NXTT -0.14
  • Stochastic Oscillator
  • NDRA 50.28
  • NXTT 6.14

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks: